» Articles » PMID: 31605295

Risk Factors Associated with Group A Streptococcus Acquisition in a Large, Urban Homeless Shelter Outbreak

Overview
Publisher Springer Nature
Specialty Public Health
Date 2019 Oct 13
PMID 31605295
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Group A Streptococcus (GAS) is a frequent cause of outbreaks in healthcare institutions, yet outbreak reports in the literature from homeless shelters are less common, despite an increased risk of severe GAS infection in homeless populations. In 2016, we conducted a case-control study to identify significant risk factors associated with GAS acquisition in a protracted, 19-month outbreak of GAS in a large, urban men's homeless shelter in Ontario, Canada.

Methods: Cases (individuals with either clinical GAS emm74 infection or asymptomatic carriers of GAS emm74) and controls were identified from shelter residents from February to September 2016. Information on demographics, clinical presentation, pre-existing health conditions, and risk factors for GAS transmission were collected for all study participants from a variety of sources, including the public health notifiable disease information system, electronic health records, the shelter electronic information system, and interviews with client services workers.

Results: From the multivariable logistic regression model, younger individuals (OR 9.1; 95% CI 1.57-52.9), those with previous skin conditions (OR 56.2; 95% CI 2.73-1160), and those with recent wounds (with wound care: OR 51.5, 95% CI 8.86-299, and without wound care: OR 77.4, 95% CI 7.38-812) were found to be at increased risk of acquiring GAS in this outbreak.

Conclusion: The outbreak investigation clearly demonstrated the need for improved wound care and infection prevention and control practices, for early screening and detection of skin and soft tissue infections, and for a comprehensive, integrated electronic information system in homeless shelters.

Citing Articles

Infectious Diseases Among People Experiencing Homelessness: A Systematic Review of the Literature in the United States and Canada, 2003-2022.

Waddell C, Saldana C, Schoonveld M, Meehan A, Lin C, Butler J Public Health Rep. 2024; 139(5):532-548.

PMID: 38379269 PMC: 11344984. DOI: 10.1177/00333549241228525.


An assessment of the airborne longevity of group A Streptococcus.

Oswin H, Blake E, Haddrell A, Finn A, Sriskandan S, Reid J Microbiology (Reading). 2024; 170(1).

PMID: 38180461 PMC: 10866022. DOI: 10.1099/mic.0.001421.


Dermatologic conditions and risk factors in people experiencing homelessness (PEH): systematic review.

Henry T, Khachemoune A Arch Dermatol Res. 2023; 315(10):2795-2803.

PMID: 37833427 DOI: 10.1007/s00403-023-02722-2.


Incidence and clinical and microbiological features of invasive and probable invasive streptococcal group A infections in children and adults in the Brussels-Capital Region, 2005-2020.

Zangarini L, Martiny D, Miendje Deyi V, Hites M, Maillart E, Hainaut M Eur J Clin Microbiol Infect Dis. 2023; 42(5):555-567.

PMID: 36881216 PMC: 9989989. DOI: 10.1007/s10096-023-04568-y.


Responding to pandemics and other disease outbreaks in homeless populations: A review of the literature and content analysis.

Babando J, Quesnel D, Woodmass K, Lomness A, Graham J Health Soc Care Community. 2021; 30(1):11-26.

PMID: 33825271 PMC: 8251050. DOI: 10.1111/hsc.13380.


References
1.
Factor S, Levine O, Schwartz B, Harrison L, Farley M, McGeer A . Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis. 2003; 9(8):970-7. PMC: 3020599. DOI: 10.3201/eid0908.020745. View

2.
Bargh G, Hoch J, Hwang S, Speechley M, Willey B, McGeer A . Group A streptococcal carriage among residents of an urban homeless shelter. Can J Infect Dis Med Microbiol. 2008; 18(5):316-7. PMC: 2533562. DOI: 10.1155/2007/629312. View

3.
Bundle N, Bubba L, Coelho J, Kwiatkowska R, Cloke R, King S . Ongoing outbreak of invasive and non-invasive disease due to group A Streptococcus (GAS) type emm66 among homeless and people who inject drugs in England and Wales, January to December 2016. Euro Surveill. 2017; 22(3). PMC: 5322289. DOI: 10.2807/1560-7917.ES.2017.22.3.30446. View

4.
Foucault C, Ranque S, Badiaga S, Rovery C, Raoult D, Brouqui P . Oral ivermectin in the treatment of body lice. J Infect Dis. 2006; 193(3):474-6. DOI: 10.1086/499279. View

5.
McNutt L, Coles F, Morse D, Menegus M, Lansky J, Bell K . Two outbreaks of primarily noninvasive group A streptococcal disease in the same nursing home, New York, 1991. Infect Control Hosp Epidemiol. 1992; 13(12):748-51. DOI: 10.1086/648349. View